Holen Sie sich die Stockscreener-App
114.18
0.02%
-0.02
Handel nachbörslich:
114.63
0.45
+0.39%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$114.20
Offen:
$114.245
24-Stunden-Volumen:
36.34M
Relative Volume:
2.85
Marktkapitalisierung:
$282.30B
Einnahmen:
$64.93B
Nettoeinkommen (Verlust:
$18.26B
KGV:
15.69
EPS:
7.2751
Netto-Cashflow:
$12.36B
1W Leistung:
-1.24%
1M Leistung:
-6.61%
6M Leistung:
+40.08%
1J Leistung:
+20.53%
1-Tages-Spanne:
$112.72
$115.18
1-Wochen-Bereich:
$112.72
$116.80
52-Wochen-Spanne:
$73.31
$125.14
Merck Co Inc Stock (MRK) Company Profile
Firmenname
Merck Co Inc
Sektor
Telefon
908-740-4000
Adresse
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, AZN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
114.18 | 282.35B | 64.93B | 18.26B | 12.36B | 7.2751 |
LLY
Lilly Eli Co
|
906.70 | 819.32B | 65.18B | 20.64B | 5.96B | 22.59 |
JNJ
Johnson Johnson
|
235.37 | 572.29B | 94.19B | 26.80B | 19.70B | 11.05 |
ABBV
Abbvie Inc
|
205.07 | 364.65B | 61.16B | 4.19B | 17.82B | 2.3614 |
AZN
Astrazeneca Plc
|
183.60 | 293.00B | 58.80B | 10.24B | 8.98B | 3.2788 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-02-20 | Eingeleitet | Barclays | Overweight |
| 2026-02-13 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-01-08 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-10-13 | Fortgesetzt | Citigroup | Neutral |
| 2025-09-17 | Herabstufung | Berenberg | Buy → Hold |
| 2025-05-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-08 | Herabstufung | Truist | Buy → Hold |
| 2024-12-20 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-04 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-11 | Herabstufung | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-03-11 | Herabstufung | Societe Generale | Hold → Sell |
| 2024-01-04 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-27 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Hold |
| 2023-04-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-03-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Eingeleitet | Jefferies | Buy |
| 2023-02-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-10-10 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-09-14 | Hochstufung | Berenberg | Hold → Buy |
| 2022-07-06 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Fortgesetzt | SVB Leerink | Outperform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Eingeleitet | Goldman | Buy |
| 2021-12-16 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-12-13 | Herabstufung | UBS | Buy → Neutral |
| 2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
| 2021-12-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-11-29 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-11-01 | Hochstufung | Argus | Hold → Buy |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-05-20 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Fortgesetzt | Bernstein | Outperform |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-08-03 | Hochstufung | Goldman | Neutral → Buy |
| 2020-06-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-16 | Eingeleitet | SVB Leerink | Outperform |
| 2019-07-03 | Eingeleitet | Mizuho | Buy |
| 2019-05-28 | Eingeleitet | Goldman | Neutral |
| 2019-05-13 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Bestätigt | Citigroup | Buy |
| 2018-10-09 | Fortgesetzt | Guggenheim | Buy |
| 2018-04-23 | Hochstufung | Goldman | Neutral → Buy |
| 2018-04-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-02-07 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Hochstufung | SunTrust | Hold → Buy |
Alle ansehen
Merck Co Inc Aktie (MRK) Neueste Nachrichten
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $125.00 - MarketBeat
'My Dad Lost Everything': Jim Cramer 'Willing To Expose' His Father For Picking The Wrong Stock — And Missing Multimillionaire OpportunityMerck & Co (NYSE:MRK) - Benzinga
Union Bancaire Privee UBP SA Decreases Stake in Merck & Co., Inc. $MRK - MarketBeat
ELISpot & FluoroSpot Assay Market Report 2026-2031: Mabtech, Oxford Immunotec Global, and Cellular Technology Dominate the Landscape - GlobeNewswire Inc.
Neville Rodie & Shaw Inc. Sells 35,140 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Park National Corp OH - MarketBeat
GAMMA Investing LLC Raises Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
AIA Group Ltd Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
Abner Herrman & Brock LLC Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
The Zacks Analyst Blog Highlights Merck, TotalEnergies and Union Pacific - The Globe and Mail
Zacks Research Upgrades Merck & Co., Inc. (NYSE:MRK) to "Hold" - MarketBeat
Merck & Co., Inc.: A new test of the support level - marketscreener.com
Citigroup Adjusts Price Target on Merck & Co. to $125 From $120, Maintains Neutral Rating - marketscreener.com
Jefferies Adjusts Price Target on Merck & Co. to $132 From $130, Maintains Buy Rating - marketscreener.com
Groupama Asset Managment Buys 49,541 Shares of Merck & Co., Inc. $MRK - MarketBeat
Payne Capital Management LLC Has $1.16 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
11,009 Shares in Merck & Co., Inc. $MRK Purchased by Lantern Wealth Advisors LLC - MarketBeat
CIBC Bancorp USA Inc. Acquires New Shares in Merck & Co., Inc. $MRK - MarketBeat
FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck An - pharmiweb.com
Merck & Co. Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs - Business Wire
MERCK & CO., INC. (MRK) - MSN
Is Merck & Co., Inc. (MRK) a good stock to buy now? - MSN
Top Analyst Reports for Merck, TotalEnergies & Union Pacific - Zacks Investment Research
Danske Bank A S Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Caerus Investment Advisors LLC Makes New $1.31 Million Investment in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Coldstream Capital Management Inc. - MarketBeat
Campbell Capital Management Inc. Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Danica Pension Livsforsikringsaktieselskab Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Captrust Financial Advisors Has $103.94 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Mariner LLC - MarketBeat
Moors & Cabot Inc. Decreases Stake in Merck & Co., Inc. $MRK - MarketBeat
National Bank of Canada FI Sells 1,834,181 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Mercer Global Advisors Inc. ADV - MarketBeat
L2 Asset Management LLC Purchases 8,812 Shares of Merck & Co., Inc. $MRK - MarketBeat
646,011 Shares in Merck & Co., Inc. $MRK Bought by Holocene Advisors LP - MarketBeat
Destination Wealth Management Cuts Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
CSM Advisors LLC Has $1.91 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Ausdal Financial Partners Inc. Purchases 9,731 Shares of Merck & Co., Inc. $MRK - MarketBeat
MRK Stock Price, Quote & Chart | MERCK & CO. INC. (NYSE:MRK) - ChartMill
Wells Fargo Raises Merck (MRK) Target on Sac-TMT Potential - Insider Monkey
MRK Stock Quote Price and Forecast - CNN
Merck & Co. (MRK) Divests Surface Solutions for €665 million - MSN
Merck & Co., Inc. (MRK) Advances Oncology Pipeline with Breakthrough FDA Designation for Ovarian Cancer Drug - MSN
Merck & Co. Inc. (NYSE:MRK) Offers a Steady Dividend Backed by Strong Fundamentals - ChartMill
Here’s Why Merck (MRK) Surged in Q4 - Insider Monkey
Merck & Co., Inc. $MRK Shares Purchased by Hamilton Wealth LLC - MarketBeat
Gotham Asset Management LLC Acquires 113,226 Shares of Merck & Co., Inc. $MRK - MarketBeat
Fayez Sarofim & Co Has $201.96 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Focus Partners Wealth Buys 22,132 Shares of Merck & Co., Inc. $MRK - MarketBeat
Finanzdaten der Merck Co Inc-Aktie (MRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):